SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001558370-24-000721
Filing Date
2024-02-02
Accepted
2024-02-02 16:31:16
Documents
4
Period of Report
2024-03-01

Document Format Files

Seq Description Document Type Size
1 DEF 14A tmb-20240301xdef14a.htm DEF 14A 218810
2 GRAPHIC tmb-20240301xdef14a_a001.jpg GRAPHIC 13092
3 GRAPHIC tmb-20240301xdef14a_bg001.jpg GRAPHIC 110071
4 GRAPHIC tmb-20240301xdef14a_bg002.jpg GRAPHIC 121037
  Complete submission text file 0001558370-24-000721.txt   556696
Mailing Address 44 MILTON AVENUE ALPHARETTA GA 30009
Business Address 44 MILTON AVENUE ALPHARETTA GA 30009 8666208655
Virios Therapeutics, Inc. (Filer) CIK: 0001818844 (see all company filings)

IRS No.: 854314201 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-39811 | Film No.: 24591996
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)